Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
phase 3
Pharma
AbbVie and Genmab’s Epkinly combo scores first-line DLBCL win
The results position Epkinly plus R-CHOP as a potential new standard of care in DLBCL.
Donavyn Coffey
Oct 6, 2026 9:11am
Taiho ph. 3 win sets up potential oral franchise expansion
Oct 1, 2026 11:38am
ESC: Cytokinetics data is first to demonstrate benefit for nHCM
Aug 28, 2026 5:50am
China IIT, Daiichi Sankyo-AZ, Leo-Tanabe—Fierce Pharma Asia
Aug 21, 2026 9:00am
Trial results set up Keenova to gain 3rd indication for Xiaflex
Jul 8, 2026 11:27am
Argenx's Vyvgart posts ph. 3 win in ocular myasthenia gravis
Feb 26, 2026 11:18am
